PluroGel on Wounds of Mixed Etiology
A Pilot Study to Investigate the Efficacy of PluroGel in Healing Venous and Mixed Aetiology Leg Ulcers
Sponsor: Medline Industries
Terminated
Business decision
Listed as NCT03275831, this NA trial focuses on Arterial Ulcer and Venous Ulcer and remains terminated or withdrawn. Sponsored by Medline Industries, it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Mar 2021 — Nov 2021 [monthly]
Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2018 — Mar 2020 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — May 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medline Industries
For direct contact, visit the study record on ClinicalTrials.gov .